173 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
3 Jul 12
A.P. Pharma Announces Positive APF530 Patient-Satisfaction Data from Phase 3 Study in Patients with Chemotherapy-Induced Nausea and Vomiting
12:00am
Exhibit 99.1
For Immediate Release
A.P. Pharma Announces Positive APF530 Patient-Satisfaction Data from Phase 3 Study in Patients with Chemotherapy … the analysis of this subset of data indicate that APF530 offered comparable nausea control and patient satisfaction to palonosetron (Aloxi®) over a 5
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
22 Jun 12
A.P. Pharma to Present APF530 Patient-Satisfaction Data from Phase 3 Study
12:00am
Exhibit 99.1
For Immediate Release
A.P. Pharma to Present APF530 Patient-Satisfaction Data from Phase 3 Study
– Poster at the Multinational … . Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today announced that the Company will present patient-satisfaction data from its
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
is expected to close on or about July 25, 2023, subject to the satisfaction of customary closing conditions.
Heron intends to use the net proceeds … , the satisfaction of customary closing conditions related to the private placement and the expected receipt and intended uses of the proceeds from the
private
8-K
HRTX
Heron Therapeutics Inc
22 Oct 09
A.P. Pharma Announces Private Equity Placement
12:00am
. The Company expects the first tranche of the Offering to close on October 22, 2009 (the “First Closing Date”), subject to satisfaction of customary … closing conditions. The Purchasers have irrevocably committed to purchase the securities, subject to satisfaction of the closing conditions.
In connection
S-8
EX-4.1
HRTX
Heron Therapeutics Inc
17 Aug 11
Registration of securities for employees
12:00am
upon the occurrence of specified events, including, without limitation, the achievement of performance goals, the satisfaction of an event … in the value of the Common Stock).
(d) Discretionary Adjustments Pursuant to Section 162(m). Notwithstanding satisfaction of any completion of any
S-8
EX-4.1
8bxx0sy
14 Jan 08
Registration of securities for employees
12:00am
S-8
EX-5.1
09hmu8ry8uubu8
9 Sep 22
Registration of securities for employees
4:06pm
8-K
EX-5.1
7muwlxhrjrqc
10 Jun 15
Heron Therapeutics, Inc. Announces Pricing of Underwritten Offering of Common Stock
12:00am
8-K
EX-5.1
own zqkx69x7hhcr4e7
8 Oct 19
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-5.1
jg2to2djs2bw
28 Jun 18
Entry into a Material Definitive Agreement
4:33pm
S-3ASR
EX-5.1
qv9gv6
28 May 21
Automatic shelf registration
4:19pm
8-K
EX-5.1
5n88yai 95
27 Jun 14
Entry into a Material Definitive Agreement
12:00am
S-8
EX-99.4
pj4wvc7xm
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-99.3
j1yjwvr2
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-99.1
z6xvh 9y0rwok
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-99.1
t80ei1rg9ahx7hsgp
9 Sep 22
Registration of securities for employees
4:06pm
8-K
5x2u44iqmy311m
19 Dec 01
Changes in registrant's certifying accountant
12:00am
8-K
kxzkn8
1 Feb 06
Changes in Registrant.s Certifying Accountant
12:00am